9-35061506-T-C
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_007126.5(VCP):c.1194+71A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0701 in 1,397,250 control chromosomes in the GnomAD database, including 5,927 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.069   (  590   hom.,  cov: 32) 
 Exomes 𝑓:  0.070   (  5337   hom.  ) 
Consequence
 VCP
NM_007126.5 intron
NM_007126.5 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  0.156  
Publications
14 publications found 
Genes affected
 VCP  (HGNC:12666):  (valosin containing protein) This gene encodes a member of the AAA ATPase family of proteins. The encoded protein plays a role in protein degradation, intracellular membrane fusion, DNA repair and replication, regulation of the cell cycle, and activation of the NF-kappa B pathway. This protein forms a homohexameric complex that interacts with a variety of cofactors and extracts ubiquitinated proteins from lipid membranes or protein complexes. Mutations in this gene cause IBMPFD (inclusion body myopathy with paget disease of bone and frontotemporal dementia), ALS (amyotrophic lateral sclerosis) and Charcot-Marie-Tooth disease in human patients. [provided by RefSeq, Aug 2017] 
VCP Gene-Disease associations (from GenCC):
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
 - inclusion body myopathy with Paget disease of bone and frontotemporal dementiaInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
 - Charcot-Marie-Tooth disease type 2YInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
 - frontotemporal dementia and/or amyotrophic lateral sclerosis 6Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
 - inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
 - adult-onset distal myopathy due to VCP mutationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - amyotrophic lateral sclerosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - frontotemporal dementia with motor neuron diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - spastic paraplegia-Paget disease of bone syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - neurodevelopmental disorderInheritance: AD Classification: LIMITED Submitted by: G2P
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86). 
BP6
Variant 9-35061506-T-C is Benign according to our data. Variant chr9-35061506-T-C is described in ClinVar as Benign. ClinVar VariationId is 1266224.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.309  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| VCP | NM_007126.5  | c.1194+71A>G | intron_variant | Intron 10 of 16 | ENST00000358901.11 | NP_009057.1 | ||
| VCP | NM_001354927.2  | c.1059+71A>G | intron_variant | Intron 10 of 16 | NP_001341856.1 | |||
| VCP | NM_001354928.2  | c.1059+71A>G | intron_variant | Intron 10 of 16 | NP_001341857.1 | 
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.0694  AC: 10553AN: 152126Hom.:  589  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
10553
AN: 
152126
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.0702  AC: 87418AN: 1245004Hom.:  5337   AF XY:  0.0720  AC XY: 45375AN XY: 630348 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
87418
AN: 
1245004
Hom.: 
 AF XY: 
AC XY: 
45375
AN XY: 
630348
show subpopulations 
African (AFR) 
 AF: 
AC: 
1334
AN: 
29012
American (AMR) 
 AF: 
AC: 
6395
AN: 
44448
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
2313
AN: 
24738
East Asian (EAS) 
 AF: 
AC: 
13323
AN: 
38696
South Asian (SAS) 
 AF: 
AC: 
9744
AN: 
81730
European-Finnish (FIN) 
 AF: 
AC: 
5082
AN: 
53030
Middle Eastern (MID) 
 AF: 
AC: 
472
AN: 
5312
European-Non Finnish (NFE) 
 AF: 
AC: 
44502
AN: 
914854
Other (OTH) 
 AF: 
AC: 
4253
AN: 
53184
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.506 
Heterozygous variant carriers
 0 
 4567 
 9134 
 13700 
 18267 
 22834 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 1698 
 3396 
 5094 
 6792 
 8490 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.0694  AC: 10563AN: 152246Hom.:  590  Cov.: 32 AF XY:  0.0738  AC XY: 5495AN XY: 74452 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
10563
AN: 
152246
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
5495
AN XY: 
74452
show subpopulations 
African (AFR) 
 AF: 
AC: 
1936
AN: 
41568
American (AMR) 
 AF: 
AC: 
1214
AN: 
15300
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
324
AN: 
3468
East Asian (EAS) 
 AF: 
AC: 
1661
AN: 
5168
South Asian (SAS) 
 AF: 
AC: 
621
AN: 
4824
European-Finnish (FIN) 
 AF: 
AC: 
987
AN: 
10596
Middle Eastern (MID) 
 AF: 
AC: 
31
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
3623
AN: 
68008
Other (OTH) 
 AF: 
AC: 
151
AN: 
2108
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.504 
Heterozygous variant carriers
 0 
 469 
 937 
 1406 
 1874 
 2343 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 130 
 260 
 390 
 520 
 650 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
660
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 15, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.